Men More At Risk Of Recurrent Blood Clots Than Women
Main Category: Blood / HematologyAlso Included In: Men's health; Vascular
Article Date: 31 Jul 2006 - 5:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Men have a 50% higher relative risk of suffering from recurrent blood clots after a first episode than women, according to an article in The Lancet. The baseline frequency of recurrent blood clots is 25% after five years.
Dr Simon McRae from the Department of Haematology (Queen Elizabeth Hospital, Woodville, South Australia, Australia) and his colleagues from the Department of Medicine, McMaster University (Hamilton, Ontario, Canada) did a meta-analysis of studies involving both men and women who were being treated for either deep vein thrombosis or pulmonary embolism (in which a clot detaches from a deep vein and lodges in the lung). They looked at rates of recurrence of blood clots in patients after they had stopped taking preventative anticoagulant (blood-thinning) medication.
A total of 5416 patients were enrolled in 15 eligible studies, 50% were men and 50% women. There were 816 recurrent blood clots, of which 523 (64%) were in men and 293 (36%) were in women.
The cause of heightened risk in men is unclear, but the authors state it could be attributable to differences in age, body mass index, or inherited susceptibility to blood clots. Dr Simon McRae writes: "further prospective studies are needed before a firm recommendation can be made to incorporate patient sex into decision making on duration of anticoagulant treatment in individual patients."
###
See also accompanying Comment.
Contact:
Dr Simon McRae
Department of Haematology and Oncology
Queen Elizabeth Hospital
Woodville, Australia
Contact: Joe Santangelo
Lancet
Visit our blood / hematology section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/48265.php>
APA
http://www.medicalnewstoday.com/releases/48265.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




